Position in JNJ
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$121,728,428
+$38,928,978 QoQ
Shares Held
497,989
+24.5% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2022CallValue
$1,772,300
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026LGT Group Foundation holds $1,040,407,974 across 8 Drug Manufacturers - General names. JNJ ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,890,121 | $372,769,659 | |
| 2 | LLY |
ELI LILLY & Co
|
399,693 | $367,625,628 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
497,989 | $121,728,428 | |
| 4 | ABBV |
AbbVie Inc.
|
413,651 | $89,964,953 | |
| 5 | PFE |
Pfizer Inc
|
2,206,233 | $61,951,021 | |
| 6 | MRK |
Merck & Co., Inc.
|
194,925 | $23,447,526 | |
| 7 | AMGN |
Amgen Inc
|
4,884 | $1,718,435 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
19,824 | $1,202,324 |
All Filings in JNJ
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $121,728,428 | 497,989 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $82,799,450 | 400,094 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $68,577,955 | 369,852 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $52,361,628 | 342,793 | Shares | Defined | 2025-07-22 | |
| 2025-03-31 | $50,969,759 | 307,343 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $41,458,066 | 286,669 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $53,172,044 | 328,101 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $62,756,569 | 429,369 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $78,994,388 | 499,364 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $76,492,409 | 488,021 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $77,870,013 | 499,968 | Shares | Defined | 2023-11-06 | |
| 2023-06-30 | $78,021,656 | 471,373 | Shares | Defined | 2023-07-27 | |
| 2023-03-31 | $78,952,040 | 509,368 | Shares | Defined | 2023-04-20 | |
| 2022-12-31 | $91,515,826 | 518,063 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $79,363,062 | 485,817 | Shares | Defined | 2022-10-19 | |
| 2022-06-30 | $94,005,033 | 529,576 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $99,782,968 | 563,014 | Shares | Defined | 2022-05-11 | |
| 2022-03-31 | $1,772,300 | 10,000 | Call | Defined | 2022-05-11 | |
| 2021-12-31 | $89,525,033 | 523,324 | Shares | Defined | 2022-05-03 | |
| No filing history on record for this holder in this stock. | ||||||